Clinical Trial Update: Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating enzalutamide with radiation therapy and hormone therapy for intermediate or high-risk prostate cancer. The study status is act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Adenocarcinoma of the Prostate, Recurrent Prostate Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING